Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study
REFLECT 研究斯洛文尼亚队列中接受一线第一代或第二代表皮生长因子受体酪氨酸激酶抑制剂治疗的非小细胞肺癌患者的真实世界疗效、治疗模式和 T790M 检测率
期刊:Radiology and Oncology
影响因子:2.2
doi:10.2478/raon-2022-0025
Turnsek, Nina; Devjak, Rok; Edelbaher, Natalija; Osrajnik, Ilonka; Unk, Mojca; Vidovic, Dusanka; Jeric, Tina; Janzic, Urska
